ZOLEDRONIC

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2017
01220042017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Persistence to denosumab or zoledronic acid was increased compared to oral bisphosphonates. INTRODUCTION Denosumab and… (More)
Is this relevant?
2014
2014
The addition of Limited Use criteria (less restrictive access) for zoledronic acid resulted in an immediate and significant… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2012
2012
We investigated the apoptosis-inducing effect of zoledronic acid in human nasopharyngeal carcinoma cell HNE-1 and explore the… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2012
2012
Bone metastases are a common and distressing effect of cancer, being a major cause of morbidity in many patients with advanced… (More)
Is this relevant?
2010
2010
INTRODUCTION Bisphosphonates have been shown to reduce osteoclastic activity and enhance pin fixation in both experimental and… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2009
2009
OBJECTIVES To evaluate the efficacy of docetaxel/prednisone and zoledronic acid in hormone refractory prostate cancer (HRPC… (More)
Is this relevant?
2007
2007
To the Editor: In their report on the Health Outcomes and Reduced Incidence with Zoledronic Acid Once Yearly (HORIZON) Pivotal… (More)
  • figure 1
  • table 1
Is this relevant?
2005
2005
Zoledronic acid is a bisphosphonate that is effective in the treatment of complications of metastatic bone disease. We have… (More)
Is this relevant?
Review
2004
Review
2004
OBJECTIVE To describe severe hypocalcemia and acute renal failure associated with zoledronic acid and interferon alfa in a… (More)
Is this relevant?